420 with CNW – Research Finds That Cannabis Helps Crohn’s Disease Sufferers

October 26, 2018 15:20:00

A team of Israeli researchers has confirmed that cannabis oil can improve the symptoms caused by Crohn’s disease. The researchers made their findings public at the 2018 UEG Week (United European Gastroenterology) that has just ended in Vienna. The event was held from October 20-24.

The lead researcher of the randomized, placebo-controlled study was Dr. Timna Naftali. He revealed at the UEG Week that their study was the very first to investigate the impact of cannabis on Crohn’s disease.

The researchers studied 46 individuals who were divided into two groups during the study. One group was given cannabis oil while the second group was given a placebo. After 8 weeks, the researchers found that 65 percent of the patients who received the cannabis oil had clinical remission of their symptoms while only 35 percent of those who got the placebo had a remission.

The scientists used tools that were standard practice for monitoring and recording how the clinical symptoms were responding during the trial period. Gut inflammation was monitored using endoscopy. Stool and blood samples were also tested for inflammatory markers during the study.

The researchers were surprised to discover that inflammation in the gut of the study participants didn’t change despite an improvement in the symptoms suffered by the individuals.

This finding disproved the long-held belief that patients improved because cannabis combated the inflammation in their gastrointestinal tract. The cannabis oil used in the study contained 15 percent CBD and 4 percent THC.

The researchers concluded that cannabis oil can now start being used as a therapy to temporarily provide relief from Crohn’s disease symptoms since it doesn’t cure the condition. Cannabis oil may be used alongside or as an alternative to the current Crohn’s disease management therapies.

The Israeli researchers plan to conduct other studies on how cannabis can be used to treat bowel inflammatory disease and other GIT diseases.

It should be remembered that the World Health Organization (WHO) is going to hold an expert meeting in November to review the classification of marijuana. The U.S. FDA also called for public comments about cannabis (its medicinal value, addiction and harm potential etc.). The findings coming in from Israel can help boost the body of evidence presented to make the case for de-scheduling marijuana as a substance which doesn’t have any therapeutic use. Several countries around the world, including Canada, Lithuania, the UK, Australia, Germany, Denmark and dozens more have legalized medical cannabis.

That list of countries should provide ample proof that cannabis has medicinal effects for a variety of conditions since each country which legalizes cannabis for medical purposes creates a list of qualifying health conditions for which patients can get a prescription or card allowing them to obtain cannabis or its products.

Cannabis industry players like ChineseInvestors.com (OTCQB: CIIX) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) must be wondering why it has taken so long for all countries to recognize the nearly endless benefits of cannabis.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office